Anti-Complement Factor D Reference Antibody (lampalizumab)
- Product Code: 139952
Molecular Weight: | Molecular Formula: | ||
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20℃ |
Product Description:
Used in the treatment of geographic atrophy (GA), a late form of age-related macular degeneration (AMD), this antibody targets complement factor D, a key enzyme in the alternative complement pathway. By inhibiting factor D, it reduces chronic inflammation and prevents uncontrolled activation of the complement system in the retina. This helps slow the progression of retinal damage and vision loss in patients with GA. Administered via intravitreal injection, it represents a targeted therapy aimed at modifying the disease course rather than just managing symptoms.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-Complement Factor D Reference Antibody (lampalizumab)
Used in the treatment of geographic atrophy (GA), a late form of age-related macular degeneration (AMD), this antibody targets complement factor D, a key enzyme in the alternative complement pathway. By inhibiting factor D, it reduces chronic inflammation and prevents uncontrolled activation of the complement system in the retina. This helps slow the progression of retinal damage and vision loss in patients with GA. Administered via intravitreal injection, it represents a targeted therapy aimed at modifying the disease course rather than just managing symptoms.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :